Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria

Journal of Neurochemistry

Volumn 66, Issue 4, 1996, Pages 1617-1624

  Davey, Gavin P ^a   Clark, John B ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Aging; Alzheimer's disease; Brain mitochondria; Complex I; Complex III; Complex IV; Flux control coefficients; Huntington's disease; Oxidative phosphorylation; Parkinson's disease; Threshold effects

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; MYXOTHIAZOL; POTASSIUM CYANIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; BRAIN OXYGEN CONSUMPTION; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME REGULATION; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

EID: 0029873904     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66041617.x     Document Type: Article

References (46)

1. Almeida A., Brooks K. J., Sammut I., Keelan J., Davey G. P., Clark J. A., and Bates T. E. (1995) Postnatal development of the complexes of the electron transport chain in synaptic mitochondria from rat brain. Dev. Neurosci 17, 212-218.
2. Beal M. F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31, 119-130.
3. Bolaños J. P., Heales S. J. R., Land J. M., and Clark J. B. (1995) Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem. 64, 1965-1972.
4. Bowling A. C. and Beal M. F. (1995) Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56, 1151-1171.
5. Bowling A. C., Mutisya E. M., Walker L. C., Price D. L., Cork L. C., and Beal M. F. (1993) Age-dependent impairment of mitochondrial function in primate brain. J. Neurochem. 60, 1964-1967.
6. Brand M. D., Hafner R. P., and Brown G. C. (1988) Control of respiration in non-phosphorylating mitochondria is shared between the proton leak and the respiratory chain. Biochem. J. 255, 535-539.
7. Brennan W. A. Jr., Bird E. D., and Aprille J. R. (1985) Regional mitochondrial respiratory activity in Huntington's disease brain. J. Neurochem. 44, 1948-1950.
8. Brown G. C. and Cooper C. E. (1994) Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 356, 295-298.
9. Brown G C., Bolaños J. P., Heales S. J. R., and Clark J. B. (1995) Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration. Neurosci. Lett. 193, 201-204.
10. Butterworth J., Yates C. M., and Simpson J. (1983) Phosphate-activated glutaminase in relation to Huntington's disease and agonal state. J. Neurochem. 41, 440-447.
11. Choi D. W., Manlucci-Gedde C., and Kriegstein A. R. (1987) Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7, 357-368.
12. Clark J. B. and Nicklas W. J. (1970) The metabolism of rat brain mitochondria. J. Biol. Chem. 193, 265-275.
13. Cleeter M. W. J., Cooper J. M., and Schapira A. H. V. (1992) Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J. Neurochem. 58, 786-789.
14. Cooper J. M., Mann V. M., and Schapira A. H. V (1992) Analysis of mitochondrial respiration chain functions and mitochondrial-DNA deletions in human skeletal muscle - effect of aging. J. Neurol. Sci. 113, 91-98.
15. Corral-Debrinski M., Horton T., Lott M. T , Shoffner J. M., Beal M. F., and Wallace D. C. (1992) Mitochondrial-DNA deletions in human brain-regional variability and increase with advanced age. Nat. Genet 2, 324-329.
16. Gellerich F. N., Bohnensack R., and Kunz W. (1983) Control of mitochondrial respiration: the contribution of adenine nucleotide translocator depends on the ATP- and ADP-consuming enzymes. Biochim. Biophys. Acta 722, 381-391.
17. Groen A. K., Wanders R. J. A., Westerhoff H. V., van der Meer R., and Tager T. M. (1982) Quantification of the contribution of various steps to the control of mitochondrial respiration. J. Biol. Chem. 257, 2754-2757.
18. Harmon H. J., Nank S., and Floyd R. A. (1987) Age dependent changes in rat brain mitochondria of synaptic and non-synaptic origins. Mech. Ageing Dev. 38, 167-177.
19. +) induces NADH dependent superoxide formation, and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem. Biophys. Res. Commun. 170, 1049-1055.
20. Heinrich R. and Rapoport T. A. (1974) A linear steady-state treatment of enzymatic chains. Eur. J. Biochem. 42, 89-95.
21. Ingebrotsen O. C., Bakken A. M., Segadal L., and Farstad M. (1982) Determination of adenine nucleotides and inosine in human myocardium by ion-pair reversed-phased high-performance liquid chromatography. J. Chromatogr. 242, 119-126.
22. Inomoto T., Tanaka A., Mori S., Jin M. B., Sato B., Yanabu N., Tokuku A., Kitai T., Ozawa K., and Yamaoka Y. (1994) Changes in the distribution of control of the mitochondrial oxidative phosphorylation in regenerating rabbit liver. Biochim. Biophys. Acta 1188, 311-317.
23. Kacser H. and Burns J. A. (1973) The control of flux, in Rate Control of Biological Processes (Davies D. D., ed), pp. 65-104. Cambridge University Press, Cambridge.
24. Kish S. J., Bergeron C., Rajput A., Dogic S., Mastrogiacomo F., Chang L.-J., Wilson J. M., DiStefano L. M , and Nobrega J. N. (1992) Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59, 776-779.
25. Lai C. K. and Clark J. B. (1979) Preparation of synaptic and non-synaptic mitochondria from mammalian brain, in Methods in Enzymology, Vol. 55 (Fleischer S. and Packer L., eds), pp. 51-60. Academic Press, New York.
26. Lestienne P., Nelson I., Riederer P., Jellinger K , and Reichmann H. (1990) Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect. J Neurochem. 55, 1810-1812.
27. Lestienne P., Nelson I., Riederer P., Jellinger K., and Reichmann H. (1991) Mitochondrial DNA in postmortem brain from patients with Parkinson's disease. J. Neurochem. 56, 1819.
28. Letellier T., Heinrich R., Malgat M., and Mazat J. P. (1994) The kinetics of threshold effects observed in mitochondrial diseases: a systemic approach. Biochem. J. 302, 171-174.
29. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275
30. Malgat M., Letellier T., Jouvaille S. L., and Mazat J. P. (1995) Value of control theory in the study of cellular metabolism - biomedical implications. J. Biol. Systems 3, 165-175.
31. Mann V. M., Cooper J. M., Javoy-Agid F., Agid Y., Jenner P., and Schapira A. H. V (1990) Mitochondrial function and parental sex effect in Huntington's disease. Lancet 336, 749.
32. 2+ concentrations. J. Biol. Chem. 260, 4028-4034.
33. Moreno-Sanchez R , Devars S., Lopez-Gomez F., Uribe A., and Corona N. (1991) Distribution of control of oxidative phosphorylation in mitochondria oxidizing NAD-linked substrates. Biochim. Biophys. Acta 1060, 284-292.
34. Mutisya E. M , Bowling A. C., and Beal M. F. (1994) Cortical cytochrome oxidase is reduced in Alzheimer's disease. J. Neurochem. 63, 2179-2184.
35. Ozawa T., Tanaka M., Ikebe S., Ohno K., Kondon T., and Mizuno Y. (1990) Quantitative-determination of deleted mitochondrial-DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis. Biochem. Biophys. Res. Commun. 172, 483-489.
36. Ragan C. I., Wilson M. T., Darley-Usmar V. M., and Lowe P. N. (1987) Subfractionation of mitochondria and isolation of the proteins of oxidative phosphorylation, in Mitochondria, A Practical Approach (Darley-Usmar V. M., Rickwood D., and Wilson M. T., eds), pp. 79-112. IRL Press, London.
37. +. Biochem. Biophys. Res. Commun. 189, 47-52.
38. Schapira A. H. V., Cooper J. M., Dexter D., Jenner P., Clark J. B., and Marsden C. D. (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1, 1296.
39. Schapira A. H. V., Cooper J. M., Dexter D., Clark J. B., Jenner P., and Marsden C. D. (1990a) Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54, 823-827.
40. 1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55, 2142-2145.
41. Shoffner J. M., Brown M. D., Torroni A., Lott M. T., Abell P., Mirra S. S., Beal M. F , Yang C. C., Gearing M., Salvo R., Watts R. L., Juncos J. L., Hanson L. A., Grain B. J., Fayad M., and Wallace D. C. (1993) Mitochondrial DNA mutations associated with Alzheimer's and Parkinson's disease. Genomics 17, 171-184.
42. Tager J. M., Wanders R. J. A., Groen A. K., Kunz W., Bohnensack R., Kuster U., Letko G., Bohme G., Duszynski J., and Wojtczak L. (1983) Control of mitochondrial respiration. FEBS Lett. 151, 1-9.
43. Taylor R. W., Birch-Machin M. A., Bartlett K., Lowerson S. A., and Turnbull D. M. (1994) The control of mitochondrial oxidations by complex III in rat muscle and liver mitochondria. J. Biol. Chem. 269, 3523-3528.
44. Tipton K. F. (1995) Might environmental factors contribute to neurodegenerative diseases? Biochem. Soc. Trans. 23, 429-435.
45. Turrens J. F. and Boveris A. (1980) Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191, 421-427.
46. Wharton D. C. and Tzagoloff A. (1967) Cytochrome oxidase from beef heart mitochondria. Methods Enzymol. 10, 245-250.